SCHEMBL19081427

SCHEMBL19081427

c1ccc(-c2c3ccccc3c(-c3ccc4c(c3)oc3c4ccc4c3oc3ccc5ccccc5c34)c3ccccc23)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 6/20 0.45
CYP1A1 P04798 4/20 0.45
CYP1A2 P05177 4/20 0.45
AHR P35869 3/20 0.45
PAX8 Q06710 2/20 0.45
FYN P06241 1/20 0.45
MAPK3 P27361 1/20 0.45
CYP1B1 Q16678 3/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPT P10636 2/20 0.39
HPGD P15428 2/20 0.39
TSHR P16473 2/20 0.39
HSD17B10 Q99714 2/20 0.39
PDE5A O76074 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
ABCB1 P08183 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP19A1 P11511 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081630 0.96 ABCG2 (0.42) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL19081481 0.94 ABCG2 (0.42) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL19081577 0.91 CYP1A1 (0.40) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL19081433 0.91 CYP1A1 (0.44) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL19081595 0.90 CYP1A1 (0.40) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL17945198 0.89 ABCG2 (0.47) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL17944289 0.89 ALOX5 (0.42) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL16067577 0.89 CYP1A1 (0.49) ABCG2CYP1A1CYP1A2CYP1B1KDM4E
SCHEMBL15461366 0.89 ABCG2 (0.49) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL19081624 0.88 ABCG2 (0.42) ABCG2CYP1A1CYP1A2AHRPAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ABCG2 4823/4885CYP1A1 184/4885CYP1A2 659/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ABCG2 4823/4885CYP1A1 184/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.